IBEX affiliate plans $706K stock sale in 2026

Affiliate Julie Casteel filed a Rule 144 notice for proposed sales of IBEX common stock from vested equity compensation.

Available on EDGAR 09/15/2026 - 04:18 PM EDT Accepted by SEC EDGAR 09/15/2026 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

IBEX Ltd (IBEX) received a Rule 144 notice indicating that affiliate Julie Casteel, through J.P. Morgan Securities LLC, plans to sell up to 17,474 shares of common stock of IBEX. The filing reports an aggregate market value of about $706,064.48 for the planned sale as of September 15, 2026.

The shares to be sold arise from equity compensation, including performance stock units (PSUs) scheduled to vest on February 6, 2026 for 16,000 shares and on June 30, 2026 for 1,604 shares.

Key Figures

Planned shares to be sold: 17,474 shares Aggregate market value: $706,064.48 PSU vesting shares (February 6, 2026): 16,000 shares +3 more

6 metrics

Planned shares to be sold 17,474 shares Maximum IBEX common shares covered by the Rule 144 notice

Aggregate market value $706,064.48 Reported value of planned share sale as of September 15, 2026

PSU vesting shares (February 6, 2026) 16,000 shares IBEX common stock from PSU vest tied to equity compensation

PSU vesting shares (June 30, 2026) 1,604 shares IBEX common stock from PSU vest tied to equity compensation

Shares outstanding figure referenced 13,389,116 shares Shares of IBEX common stock referenced in the securities information section

Notice date September 15, 2026 Date associated with the Rule 144 securities information

Key Terms

Rule 144, affiliate, Equity Compensation, PSU Vest

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

affiliate regulatory

"affiliate"

Equity Compensation financial

"06/30/2026 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

PSU Vest financial

"06/30/2026 | PSU Vest | IBEX Ltd (Issuer)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for IBEX (IBEX)?

It discloses that affiliate Julie Casteel, using J.P. Morgan Securities LLC as broker, plans to sell up to 17,474 shares of IBEX common stock under Rule 144, with an aggregate market value of about $706,064.48 as of September 15, 2026.

How many IBEX (IBEX) shares are planned to be sold under this Form 144?

The notice reports a proposed sale of up to 17,474 shares of IBEX common stock. This amount is tied to equity compensation awards held for the account of affiliate Julie Casteel.

What is the reported market value of the IBEX (IBEX) shares in this Form 144?

The filing reports an aggregate market value of approximately $706,064.48 for the planned sale of IBEX common stock as of September 15, 2026.

What is the source of the IBEX (IBEX) shares to be sold by Julie Casteel?

The shares come from equity compensation, specifically performance stock units (PSUs) scheduled to vest into 16,000 shares on February 6, 2026 and 1,604 shares on June 30, 2026.

Which broker is handling the proposed IBEX (IBEX) share sale under Rule 144?

The proposed sale of IBEX common stock is to be handled by J.P. Morgan Securities LLC, identified in the filing as the broker for the transaction.

On which market are the IBEX (IBEX) shares listed in this Form 144?

The shares referenced in the Form 144 are listed on NASDAQ, as indicated in the securities information section of the filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001974084
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IBEX LIMITED
SEC File Number	001-38442
Address of Issuer	1717 PENNSYLVANIA AVENUE NW SUITE 825 WASHINGTON DISTRICT OF COLUMBIA 20006
Phone	202-580-6200
Name of Person for Whose Account the Securities are To Be Sold	Julie Casteel
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	J.P. Morgan Securities LLC 270 Park Ave 10th Floor New York NY 10017	17474	706064.48	13389116	09/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/30/2026	PSU Vest	IBEX Ltd (Issuer)			1604	06/30/2026	Equity Compensation
Common	02/06/2026	PSU Vest	IBEX Ltd (Issuer)			16000	02/06/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	J.P. Morgan Securities LLC, Workplace Solutions, as Agent and Attorney in Fact for Julie Casteel, IBEX Limited
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)